Literature DB >> 19317642

Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression.

William Rust1, Thavamalar Balakrishnan, Robert Zweigerdt.   

Abstract

AIMS: The production of a homogenous population of human cardiomyocytes that can be expanded in vitro may facilitate development of replacement tissue lost as a result of cardiac disease and injury.
MATERIALS AND METHODS: We evaluated the utility of activated leukocyte cell-adhesion molecule, CD166 (ALCAM) expression as a marker for isolating cardiomyocytes from differentiating cultures of human embryonic stem cells (hESCs). Using RT-qPCR, immunohistochemistry and DNA methylation studies, we evaluated the developmental age of hESC-derived cardiomyocytes. RESULTS AND
CONCLUSIONS: We demonstrate that cardiomyocytes derived from hESC cultures express ALCAM and that this surface antigen can be used to select a population of differentiated cells that are enriched for cardiomyocytes. Expression of contractile proteins and ion channels, and DNA methylation patterns, suggest that ALCAM-enriched cardiomyocytes have an embryonic phenotype. Selected cardiomyocyte populations survive sorting, adhere to collagen-coated tissue culture plastic and proliferate in short-term culture. Long-term in vitro survival of cardiomyocytes was achieved by culturing cells in 3D aggregates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317642     DOI: 10.2217/17460751.4.2.225

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  19 in total

Review 1.  Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications.

Authors:  Hilmar Vidarsson; Johan Hyllner; Peter Sartipy
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 2.  Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.

Authors:  Pieterjan Dierickx; Pieter A Doevendans; Niels Geijsen; Linda W van Laake
Journal:  J Cardiovasc Transl Res       Date:  2012-07-18       Impact factor: 4.132

3.  Efficient generation of human embryonic stem cell-derived cardiac progenitors based on tissue-specific enhanced green fluorescence protein expression.

Authors:  Kornélia Szebényi; Adrienn Péntek; Zsuzsa Erdei; György Várady; Tamás I Orbán; Balázs Sarkadi; Ágota Apáti
Journal:  Tissue Eng Part C Methods       Date:  2015-01       Impact factor: 3.056

Review 4.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

5.  Engineered human cardiac tissue.

Authors:  Kareen L Kreutziger; Charles E Murry
Journal:  Pediatr Cardiol       Date:  2011-02-04       Impact factor: 1.655

6.  High-purity enrichment of functional cardiovascular cells from human iPS cells.

Authors:  Bo Lin; Jong Kim; Yanxin Li; Haiying Pan; Xonia Carvajal-Vergara; Guy Salama; Tao Cheng; Yong Li; Cecilia W Lo; Lei Yang
Journal:  Cardiovasc Res       Date:  2012-06-06       Impact factor: 10.787

Review 7.  Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.

Authors:  Adriana Blazeski; Renjun Zhu; David W Hunter; Seth H Weinberg; Kenneth R Boheler; Elias T Zambidis; Leslie Tung
Journal:  Prog Biophys Mol Biol       Date:  2012-08-07       Impact factor: 3.667

Review 8.  Cell surface markers for immunophenotyping human pluripotent stem cell-derived cardiomyocytes.

Authors:  Kenneth R Boheler; Ellen Ngar-Yun Poon
Journal:  Pflugers Arch       Date:  2021-04-30       Impact factor: 3.657

9.  Cardiac differentiation of pluripotent stem cells.

Authors:  Kristiina Rajala; Mari Pekkanen-Mattila; Katriina Aalto-Setälä
Journal:  Stem Cells Int       Date:  2011-04-04       Impact factor: 5.443

10.  Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.

Authors:  Hideki Uosaki; Hiroyuki Fukushima; Ayako Takeuchi; Satoshi Matsuoka; Norio Nakatsuji; Shinya Yamanaka; Jun K Yamashita
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.